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Abstract
congestive heart failure as a cause of acute liver fail-
ure is rarely documented with only a few cases.
although  the  pathophysiology  is  poorly  under-
stood, there is rising evidence, that low cardiac output
with consecutive reduction in hepatic blood flow is a
main causing factor, rather than hypotension. In the
setting of acute liver failure due to congestive heart
failure, clinical signs of the latter can be absent, which
requires an appropriate diagnostic approach.
as a reference center for acute liver failure and liver
transplantation  we  recorded  from  May  2003  to  De-
cember 2007 202 admissions with the primary diag-
noses acute liver failure. 13/202 was due to congestive
heart  failure,  which  was  associated  with  a  mortality
rate of 54%. leading cause of death was the underly-
ing  heart  failure.  asparagine  transaminase  (ast),
bilirubin, and international normalized ratio (InR) did
not differ significantly in surviving and deceased pa-
tients at admission. Despite both groups had signs of
cardiogenic shock, the cardiac index (cI) was signifi-
cantly  higher  in  the  survival  group  on  admission  as
compared with non-survivors (2.1 l/min/m2 vs. 1.6
l/min/m2, p=0.04). central venous - and pulmonary
wedge pressure did not differ significantly. Remarkable
improvement  of  liver  function  was  recorded  in  the
group, who recovered from cardiogenic shock. 
In conclusion, patients with acute liver failure re-
quire an appropriate diagnostic approach. congestive
heart failure should always be considered as a possible
cause of acute liver failure.
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IntRoDuctIon
acute liver failure (alF) is defined as an abrupt onset
of jaundice, hepatic encephalopathy, and coagulopa-
thy  in  the  absent  of  pre-existing  liver  disease  [11].
cardiomyopathy as the underlying cause of alF is
rare and only a few case reports are documented in
the literature [5, 7, 8, 18].  cardiac decompensation
can initially be undetected, and the usual signs of con-
gestive  heart  failure  may  be  absent  [5,  18].  Both,
chronic and acute congestive heart failure can lead to
hepatic  dysfunction  [10,  17].  although  there  is  no
classic  pattern  of  abnormalities,  a  cholestatic  bio-
chemical profile is common, with a mild elevation in
total bilirubin (usually 3 g/dl), a mild elevation in al-
kaline phosphatase and only occasional elevations in
transaminases. another common observation is an in-
crease in InR. the presumed causes of hepatic dys-
function in congestive heart failure are hepatic con-
gestion from venous outflow obstruction and result-
ing hypertension and decreased oxygen delivery from
an impaired cardiac output [10]. the latter has been
hypothesised to result from the fairly fixed portion of
the  cardiac  output  that  supplies  the  hepatic  bed
(about 20%). once the decrease in hepatic oxygen de-
livery crosses a critical threshold, a cascade of events
is initiated that ultimately results in hemorrhagic cen-
trilobular necrosis [2, 10]. 
During a five year period we identified 13 patients
with alF due to congestive heart failure, which was
diagnosed by right heart catheterisation, transthoracic
echocardiography and laboratory data.
the aim of our study was to determine the clinical
course and laboratory features in patients with alF
induced by congestive heart failure.
PatIEnts anD MEtHoDs
the study was conducted in accordance with the Dec-
laration of Helsinki.
Between May 2003 and December 2007 we record-
ed 202 admissions at our Intensive care unit (Icu)
with the primary diagnoses alF. 95 of these patients
had  signs  of  an  acute  decompensation  of  chronic 
liver disease. the remaining patients fulfilled the crite-
ria of alF according to o’grady et al. [11]. 13 of
these 107 patients (10.3%) suffered from alF caused
by congestive heart failure (see Fig. 1). Interestingly, 7
of  the  13  patients  were  referred  from  cardiology 
departments.  although,  patients  had  a  well  known
history of chronic heart deficiency, all referring cen-
ters excluded any association between cardiac failure
and alF due to absence of clinical signs of cardiac
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echocardiography as compared with earlier examina-
tions. However, hemodynamic evaluations with right
heart catheter were not performed in these centers.
the remaining 6 patients were referred from general
medical wards.
stanDaRD PRocEDuRE FoR PatIEnts WItH acutE
lIvER FaIluRE
our workup in all patients, who were admitted with
the  suspicion  of  alF  consists  of  an  ultrasound
Doppler, particular of the liver, to exclude an acute
Budd-chiari  syndrome.  Blood  flow  measurements
were  performed  using  sonographic  equipment  with
color Doppler capability (siemens sonoline, Erlangen,
germany) and a 3.5 MHz probe to determine tracing
in the portal vein (Pv), the hepatic artery (Ha) and
the hepatic vein (Hv). Moreover, special laboratory in-
vestigation for all other possible diagnoses which are
associated with an alF, e.g. viral hepatitis (a and B),
autoimmune hepatitis, M. Wilson, drug-related toxicity
(particular acetaminophen), HEllP –syndrome were
performed.  laboratory  routine  work-up  was  per-
formed daily and included at least total bilirubin, ast,
alanine transaminase (alt), and InR.
assEssMEnt oF HEaRt FaIluRE
In cases, where the cause of alF remained unknown
the patients were scheduled for a right heart catheteri-
sation to exclude cardiac failure.
normal values for the pulmonary artery catheteri-
zation  assessment  were  defined  according  to  shoe-
maker [14]:
Cardiac Index (CI): 2.8 l/min/m2, pulmonary capil-
lary wedge pressure
(PCWP): 12-15 mmHg, central venous pressure 
(CVP): 5- 10 mmHg
Systemic vascular resistance (SVR):
900-1500 dyn*sec*cm-5, 
pulmonary vascular resistance (PVR):
90 -180 dyn*sec*cm-5
Mean arterial pressure (MaP), mean pulmonary ar-
terial pressure (MPaP),  cvP, and PcWP were record-
ed  using  standard  disposable  pressure  transducers
(Medex  Medical,  Klein-Winternheim,  germany),  to-
gether with leads II and v5 of the electrocardiogram
for the detection of heart rate (sirecust 1281 siemens,
germany).  cardiac  output  was  measured  by  a  ther-
modilution method, using the stewart-Hamilton equa-
tion (18). the cI was calculated by dividing the car-
diac output by the Body surface area (Bsa). transtho-
racic echocardiography was used for global assessment
of the heart, estimating of the ejection fraction and
contractility of the right and left ventricle.
statIstIcal analysIs
the categorical variables were analyzed by chi-squared
test with yates correction; whereas continuous variables
were analyzed by one-way analysis of variance and post
hoc scheffe test when normal distribution was given.
non-normally  distributed  continuous  variables  were
analyzed  by  Kruskal-Wallis  one-way  analysis  of  vari-
ance on ranks. P< 0.05 was considered significant.
REsults
We identified 13 patients (male: 8, female: 5) during the
time period of May 2003 to December 2007 with acute
liver failure caused by cardiac failure (Fig. 1). the mean
age of the patients was 48.4 ﾱ 17.4 years. all patients
suffered from cardiogenic shock at admission.
causEs oF HEaRt FaIluRE
six patients suffered from dilatative cardiomyopathy
(ejection fraction ≤ 20%) with acute decompensation.
two patients developed pericardial tamponade follow-
ing cardiac surgery. one patient suffered from pulmo  -
nary embolism and consecutive right heart failure, one
patient experienced aortic valve stenosis IIIﾰ (aortic
root 0.4 cm2) with secondary pulmonary hypertension
and  right  heart  failure.  two  patients  were  admitted
with a myocardial infarction, and one patient with a
known primary pulmonary hypertension had an acute
right heart failure due to tachyarrhythmia absoluta.
outcoME
the overall hospital mortality rate was 54% (7 out of
13). 7 patients died within 4 days due to heart failure
and were not accompanied with liver failure.
the  remaining  6  patients  recovered  from  cardio-
genic shock and improved in their clinical course. the
patient with the aortic valve stenosis underwent a suc-
cessful valve replacement and recovered. the patient
with the pulmonary embolism was treated with fibri-
nolyses  and  recovered.  all  surviving  patients  were
readmitted to the referring hospital with remarkable
improved cardiac - and liver function.
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Fig. 1. admission at Intensive care unit (Icu) with the pri-
mary diagnoses acute liver failure in the time period 5/2003-
12/2007. Pts: patients; alF: acute liver failure, cHF: conges-
tive heart failure.
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ast, alt, bilirubin, and InR did not differ statistical-
ly on admission between patients, who survived or de-
ceased. ast was significantly lower in the surviving
group on day 7 as compared with all patients at admis-
sion (1043 ﾱ 1013 u/l vs 4029 ﾱ 3514 u/l). al-
though, bilirubin, alt decreased and InR increased,
these  apparent  differences  did  not  reach  statistically
significance (see table 1 and Fig. 2)
HEMoDynaMIcs
all patients suffered from cardiogenic shock (cI = 1.9
l/min/m2). However, patients who survived had sig-
nificant  higher  cI  as  compared  with  non-survivors
(2.1 ﾱ 0.2 l/min/m2 vs. 1.6 ﾱ 0.5 l/min/m2). there
were no significant differences in other cardiovascular
parameters between both groups on admission [cvP
(17 ﾱ 4 mmHg in survival group vs, 15 ﾱ 6 mmHg
non-survival), PcWP (20 ﾱ 6 mmHg survival group,
20 ﾱ 12 mmHg non-survival group), and MPaP (32 ﾱ
10 mmHg survival group vs. 46 ﾱ 21 mmHg non-sur-
vival group)].
Echocardiogram was performed in all patients that
revealed  global  hypokinesis  with  estimated  ejection
fraction ≤ 20%. 
Dobutamine as inotropic support was infused in 3
patients (dose 2-8 ﾵg/kg/min), milrinone was used for
2 patients (dose 0.5-3 ﾵg/kg/min), or adrenaline (8 pa-
tients, dose ≤ 0.1 ﾵg/kg/min). noradrenaline as a va-
sopressor was used in all patients to maintain a MaP
of 70 mmHg. 
Patients who survived showed a significant increase
of cI at day 7 compared with all patients at admission.
cvP and vasopressor support (noradrenalin) was sig-
nificantly  reduced  at  day  7  in  the  survival  group  as
compared with baseline (see table 1).
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Table  1.  laboratory  and  hemodynamic  values  at  time  of
trans  fer  to  our  department  and  at  day  7  of  the  survived 
patients.
value admission Day 7
ast (u/l) 4029 ﾱ 3514 1043 ﾱ 1013*
alt (u/l) 2685 ﾱ 2088 1193 ﾱ 1068
Bilirubin (u/l) 4.3 ﾱ 3.1 2.2 ﾱ 1.3
InR 2.4 ﾱ 1.3 1.7 ﾱ 0.5
HR (1/min) 105 ﾱ 26 115 ﾱ 28
MaP (mmHg) 71 ﾱ 15 73 ﾱ 9
cvP (mmHg) 16 ﾱ 5 11 ﾱ 2 *
cI (l*min-1*m2) 1.9 ﾱ 0.9 3 ﾱ 1*
MPaP (mmHg) 40 ﾱ 19 27 ﾱ 7
PcWP (mmHg) 20 ﾱ 10 15 ﾱ 5 
svR (dyn*sec*cm-5) 1713 ﾱ 525 922 ﾱ 236
PvR (dyn*sec*cm-5) 327 ﾱ 146 202 ﾱ 49
noradrenaline (ﾵg/kg/min) 0.9 ﾱ 0.6 0.2 ﾱ 0.1*
*P < 0.05
Fig. 2. asparagine transaminase (ast) course of all patients
during 1 week after admission. on day 7 only 6 of 13 patients
were alive and showed a significant  ast decrease as com-
pared with baseline on admission.
Fig. 3. Portal vein tracing showed a partial reversed flow on admission (a). after cardiac recovery the flow pattern remained
pulsatile, but hepatopedal (b).
a b
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InvEstIgatIon
In all patients the doppler tracing documented severe
impairment of portal vein flow with partial reversed
flow without signs of a portal vein thrombosis (see
Fig. 3). a repeated ultrasound in the survival group on
day 5 showed a remarkable improved portal vein trac-
ing with pulsatile, but hepatopedal flow pattern.
the  hepatic  vein  preserved  its  triphasic  pattern,
however with a remarkable increased retrograde flow
(see  Fig.  4).  after  cardiac  recovery  the  retrograde 
flow decreased. the hepatic artery showed a regular
flow tracing despite a high dose of vasopressor treat-
ment.
DIscussIon
In  our  study  we  identified  13  patients  with  alF
caused  by  congestive  heart  failure.  all  patients  suf-
fered from cardiogenic shock, however patients that
survived  had  significant  higher  cI  on  admission  as
compared  with  non-survivors.  the  overall  hospital
mortality was 54%. Patients who survived had a regu-
lar cI on day 7, which was associated with improved
liver function. ultrasound Doppler images on admis-
sion showed pathological traces of portal- and hepatic
vein, which were reversed after cardiac recovery.
Heart failure is a most often accompanied by of el-
evated  plasma  concentrations  of  liver  enzymes  [10,
17]. only Kubo et al. [9] reported a slight ast eleva-
tion  (65  ﾱ  82  u/l)  in  patients  with  a  cI  ≤  1.5
l/min/m2. However, most other reports (Wiesen et
al. [18]; Fussell et al. [4]) support the findings of our
present study, where ast concentrations were shown
to be elevated more than 2000-fold, despite a mean cI
of 1.9 l/min/m2 . the main difference of Kubo’s re-
port and the other studies are that Kubo described the
incidence and severity of liver function abnormalities
in patients with congestive heart failure, but in absence
of acute decompensation. Despite a very low cI in his
study,  which  did  occur  not  abruptly,  compensatory
mechanisms may react (additional liver veins draining
from  diaphragmal  veins  or  vena  gastrica  sinistra),  if
there is time enough to create this bypass.
Fulminant  hepatic  failure  caused  by  congestive
heart failure has rarely been documented; furthermore
the exact pathophysiology remains unclear. seeto et al.
[13] stated that systemic hypotension or shock alone
did not lead to liver failure in any patient. the majority
of patients in their study with liver failure had severe
underlying cardiac disease that had often led to passive
congestion of the liver. they conclude that right-sided
heart  failure  resulting  in  hepatic  venous  congestion,
may predispose the liver to hepatic injury induced by a
hypotensive event. the most presumed causes of car-
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High backflow into the liver 
due to cardiogenic shock
Remarkable decreased backflow
after cardiac recovery
Fig. 4. Doppler wave form of the hepatic vein (middle). the trace showed a triphasic wave with an increase of the retrograde
phase in the hepatic vein (a). after cardiac recovery the hepatic vein tracing showed nearly normal pattern, with remarkable de-
crease of the retrograde flow (b).
b
a
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hypertension  and  decreased  oxygen  delivery  (Do)
from a decreased cI [17]. once Do underwent a criti-
cal threshold, hepatic hypoxia initiates a process that
results in hemorrhage centrilobular necrosis [2]. ve-
nous hypertension results in periventricular sinusoidal
congestion, endothelial injury, replacement of hepato-
cytes with erythrocytes, and ultimatively, centrilobular
necrosis [2, 6]. In our study patients fulfilled all criteria
for cardiogenic shock with elevated cvP. Patients who
survived  and  recovered  from  cardiogenic  shock  re-
mained a high cvP, but showed an improvement in
liver function. this led us to the conclusion that a low
cI  has  more  impact  on  the  liver  congestion  than  a
high cvP. Indeed, a low cI induces a high cvP which
ultimately may cause liver congestion. However, an as-
sociation of liver failure with high cvP (> 10 mmHg)
as a sign of volume overload but regular cI has never
been reported.
the  Doppler  ultrasound  pattern  of  reversed  pul-
satile flow (RPF) of the Pv is strongly associated with
high right atrial pressure (> 20 mmHg) [1, 12]. tricus-
pid regurgitation is considered to be the main cause of
RPF in patients with congestive heart failure, but the
precise  pathophysiological  mechanism  of  the  portal
veins RPF remains unsolved. In our study the Pv flow
was only partially reversed, but with very severe im-
paired hepatopedal flow. after improvement of car-
diac function the hepatopedal flow improved but re-
mained pulsatile. a very similar RPv was reported in
patients with a Budd-chiari syndrome [16]. this syn-
drome leads to occlusion of the hepatic vein and/or
inferior vena cava and therefore resembles the situa-
tion of elevated right atrial pressure. the venous out-
flow obstruction of the liver leads to increased portal
vein and hepatic sinusoid pressures as the blood flow
stagnates with total or partial RPv flow [3]. 
Hepatic vein flow in healthy volunteers consists of
two forward flows toward the heart; one systole, the
other one in diastole, and one retrograde flow toward
the liver during atrial contraction [15]. In patients with
atrial  fibrillation,  and  more  pronounced  in  patients
with congestive heart failure a systolic backward flow
toward  the  liver  is  reported  [19].  In  our  study  we
found a major backflow toward the liver at both cycle
systolic and diastolic. after cardiac recovery the hepat-
ic vein flow improved and was mainly directed out of
the liver. 
as any observational cohort study, our report has
some limitations.  First of all we performed a retro-
spective study were the findings of such an investiga-
tion  carry  less  persuasive  force  than  those  of  a
prospective study. In order of our limited sample size
we were not able to abbreviate special recommenda-
tion  for  treatment  for  these  patients.  Moreover  we
were not able to make any conclusions about the epi-
demiology of alF caused by cardiac failure. However,
what we learned form our data is that every patient
with unknown cause of alF should be evaluated with
right  heart  catheter  to  exclude  cardiac  induced  liver
failure. the only curative treatment option for these
patients is to improve cardiac function.
In conclusion, alF induced by heart failure is rare
and carries a high mortality rate. In case of unknown
cause of alF, despite a meticulous workup, cardiac
failure  should  always  be  considered.  Right  heart
catheter evaluation for exact assessment of cI, MPaP,
and cvP is mandatory for these patients. 
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